ERS International Congress, Milan 2017

---

Towards better treatments for lung disease: experimental pharmacology

Thematic Poster
Chairs: N. Frossard (Illkirch, France), A. Larsson-Callerfelt (Lund, Sweden), S. Bonvini (London, United Kingdom), R. Saunders (Leicester, United Kingdom)

A case control study:The role of leukotriene receptor antagonist in cardiovascular risk M. Hoxha (Tirane, Albania)
Effect of salmetrol-fluticason combination and tiotropium on clinical and physiological improvement of bronchial anthracofibrosis, a double blind randomized, cross over, placebo controlled, clinical trial. M. Mirsadraei (Mashhad, Islamic Republic of Iran)
LPA1 antagonists BMS-986020 and BMS-986234 for idiopathic pulmonary fibrosis: Preclinical evaluation of hepatobiliary homeostasis G. Rosen (Lawrenceville, United States of America)
Effect of exendin-4 on lung function of diabetic patients: a preliminary report P. Rogliani (Roma, Rm, Italy)
CHF 6001 inhibits nuclear translocation of NF-?B in LPS-induced lung inflammation in mice F. Stellari (Parma, Pr, Italy)
Bufei Jianpi granules decrease skeletal muscular cell apoptosis via improving mitochondrial dysfunction in rats with chronic obstructive pulmonary disease J. Mao (zhengzhou,henan,, China)
The combination of PDE4 and PDE5 inhibitors reduces YAP expression in IPF S. Contreras (VALENCIA, Spain)
Meta-analysis of two clinical trials: Slowing respiratory decline in Duchenne muscular dystrophy (DMD) M. Leinonen (Liestal, Switzerland)
Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1 T. Hwang (Taoyuan, Taiwan)
VEGF induces ECM synthesis and fibroblast activity in human lung fibroblasts A. Larsson-Callerfelt (Lund, Sweden)
Clinically-relevant computational model of airway remodelling to design and optimise interventions to treat asthma H. Kaul (Toronto, Canada)
Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma. E. Kogut (Warszawa, Poland)
Anti-inflammatory effects of Low Level Laser (LLL) in a murine model of asthma and its combination with the standard treatment A. De Brito Léia (Vargem Grande Paulista, Brazil)
Bufei Yishen granules decrease inflammation and extracellular matrix deposition in airway remodeling in chronic obstructive pulmonary disease rats Y. Li (Zhengzhou, China)
Anti-IL17 treatment controls airway asthmatic responses exacerbated by LPS L. Aristoteles (Santos/Sp, Brazil)
Anti IL-17 with or without Rho kinase inhibitor in mice with chronic allergic pulmonary inflammation T. Santos (SAO PAULO/SP, Brazil)
Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat M. Boskabady (Mashhad, Islamic Republic of Iran)
Pharmacological validation of a new IPF bleomycin-induced mouse model F. Stellari (Parma, Pr, Italy)
Effect of ambroxol on whole lung mucociliary clearance in sheep. S. Koelsch (Frankfurt, Germany)
Interaction between tiotropium  bromide and olodaterol in small human airways L. Calzetta (Roma, Rm, Italy)